Didier Frappaz

39PUBLICATIONS
406CO-AUTHORS
Molecular targetsPredictive and prognostic markersInfant and child healthCancer therapy (excl. chemotherapy and radiation therapy)Central nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Jul 15, 2026
Erdafitinib in Patients With Advanced Solid Tumors With FGFR Alterations (RAGNAR): Results of Tumor-Specific Analyses and Secondary Cohorts.

|Jul 10, 2026
The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

|Jul 03, 2026
Spatial transcriptomic atlas of aggressive osteosarcomas reveals shared immune landscape and targetable surface markers.

|Jun 13, 2026
Paediatric Therapeutic Development Workshop on rhabdomyosarcoma.

|Mar 16, 2026
Phase I/II Study of the CDK2/9 Inhibitor Fadraciclib in Combination with Chemotherapy in Children with Advanced Malignancies: Arm K of the AcSé-ESMART Trial.

Alba Rubio-San-Simón, Lynley V Marshall, Eleni Karamouza

|Jan 27, 2026
Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial.

Susanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff

Pageof 7

Frequent Collaborators

9 joint publications

Gudrun Schleiermacher

7 joint publications

Maria Eugenia Marques da Costa

7 joint publications

Gaelle Pierron

7 joint publications

Nicolas Andre